Anju Shrestha

Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA

Poster(s):

• (C-214) Second Primary Malignancy in Patients with Multiple Myeloma Receiving Chimeric Antigen Receptor T-Cell Therapy and Other Systemic Anticancer Therapy: A Comparative Study Using a Real-World Database
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET